CN1739740A - Externally applied medicine of fewleaf schnabelia herb - Google Patents

Externally applied medicine of fewleaf schnabelia herb Download PDF

Info

Publication number
CN1739740A
CN1739740A CN 200510098929 CN200510098929A CN1739740A CN 1739740 A CN1739740 A CN 1739740A CN 200510098929 CN200510098929 CN 200510098929 CN 200510098929 A CN200510098929 A CN 200510098929A CN 1739740 A CN1739740 A CN 1739740A
Authority
CN
China
Prior art keywords
herba
parts
medicine
radix
externally applied
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510098929
Other languages
Chinese (zh)
Other versions
CN100551418C (en
Inventor
王浩贵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2005100989293A priority Critical patent/CN100551418C/en
Publication of CN1739740A publication Critical patent/CN1739740A/en
Application granted granted Critical
Publication of CN100551418C publication Critical patent/CN100551418C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention is one kind of externally applied medicine. The medicine is prepared with seven kinds of Chinese medicinal materials including fewleaf schnabelia herb, manyflowre supplejack root, winterberry euonymus root-bark and fruit, flaccid anemone rhizome, curious kadsura, etc. in certain proportion as well as alcohol solution in 75 % concentration. The synergistic effect of the Chinese medicinal materials makes the externally applied medicine possess high and determined effect and short treatment period on traumatic injury, rheumatalgia, soft tissue injury, rheumarthritis and other diseases.

Description

A kind of Herba Schnabeliae Oligophyllae medicine for external use
Technical field:
The present invention relates to a kind of Herba Schnabeliae Oligophyllae medicine for external use.
Background technology:
The traumatic injury disease is a kind of common disease, it is a lot of from ancient times to the present to suffer from the somebody, be subjected to ailing the torment deeply, the various medicine for external use of Xiao Shouing are also a lot of in the market, but no matter be Western medicine or Chinese medicine, slight illness for this class Drug therapy traumatic injury has played certain therapeutical effect really, but does not also have a kind of specific drug of ideal treatment traumatic injury.
Summary of the invention:
The inventor is at above-mentioned weak point, and it is convenient to have a kind of treatment at pressing for of patient, eutherapeutic medicine for external use; The inventor, verifies and by clinical trial repeatedly through research repeatedly, finally developed a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compare with existing similar medicine for external use curative effect, better efficacy is a kind of medicine for external use of very ideal traumatic injury.
Purpose of the present invention just provides a kind of Herba Schnabeliae Oligophyllae medicine for external use.
Choice of drug Herba Schnabeliae Oligophyllae of the present invention, Radix Berchemiae Giraldianae, Herba Euonymi Bungeani, Rhizoma Anemones flaccidae, Radix seu Caulis Kadsurae Heteroclitae, Herba Psiloti Nudi, Radix Doellingeriae, ethanol (concentration is 75%) are formed; Wherein select Herba Schnabeliae Oligophyllae for use: have dispelling wind and removing obstruction in the collateral, eliminating stasis to stop pain; Control traumatic injury, rheumatic arthralgia, the rheumatic bones and muscles pain, lumbago is fallen the damage joint and is swollen and ache.Select Radix Berchemiae Giraldianae for use: have wind-damp dispelling, promoting blood circulation to remove obstruction in the collateral; Control traumatic injury, rheumatic arthritis.Select Herba Euonymi Bungeani for use: have expelling wind and removing dampness, promoting blood circulation and stopping pain; Control lumbago, rheumatic arthritis.Select Rhizoma Anemones flaccidae for use: have expelling wind and removing dampness, relaxing muscles and tendons to promote blood circulation; Dispelling the wind and dampness pathogens pain, traumatic injury.Select Radix seu Caulis Kadsurae Heteroclitae for use: have expelling wind and removing dampness, promoting flow of QI and blood; Control traumatic injury, rheumatic ostalgia.Select Herba Psiloti Nudi for use: have expelling wind and removing dampness, relaxing muscles and tendons and activating QI and blood in the collateral; The dispelling the wind and dampness pathogens arthralgia pain, arthralgia.Select Radix Doellingeriae for use: have the dispelling wind circulation of qi promoting, promoting blood circulation and stopping pain.Control arthralgia, traumatic injury.Make the effect of each medicine produce collaborative effect these drug regimens, thereby can realize effectively treating traumatic injury, rheumatic bones and muscles pain, fall decrease that joint swells and ache, rheumatic arthritis, traumatic injury muscles and bones are hindered, blood stasis swells and ache, the curative effect of disease of soft tissue contusion, rheumatic arthritis, rheumatic arthritis, treating swelling and pain by traumatic injury is definite, the course of treatment is shorter, and effect is better.
The consumption of drug component of the present invention also is to carry out a large amount of solid lines through the inventor to grope to sum up and draw, and each amounts of components is for all to have better therapeutic effect in the following weight parts scope; It is made up of the component of following parts by weight:
Herba Schnabeliae Oligophyllae 1-16 part, Radix Berchemiae Giraldianae 1-14 part, Herba Euonymi Bungeani 1-8 part, Rhizoma Anemones flaccidae 1-10 part, Radix seu Caulis Kadsurae Heteroclitae 1-10 part, Herba Psiloti Nudi 1-10 part, Radix Doellingeriae 1-10 part, ethanol (concentration is 75%) 30-255 part.
Optimization formula of the present invention is:
14 parts of Herba Schnabeliae Oligophyllaes, 12 parts of Radix Berchemiae Giraldianae, 6 parts of Herba Euonymi Bungeani, 8 parts of Rhizoma Anemones flaccidae, Radix seu Caulis Kadsurae Heteroclitae 8,8 parts of Herba Psiloti Nudis, 8 parts of Radix Doellingeriaes, 215 parts of ethanol (concentration is 75%).
A kind of Herba Schnabeliae Oligophyllae medicine for external use of the present invention has relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation to remove blood stasis, an effect of the analgesia of dispeling the wind; Be applicable to treatment traumatic injury, rheumatic bones and muscles pain, fall decrease that joint swells and ache, rheumatic arthritis, traumatic injury muscles and bones are hindered, blood stasis swells and ache, the disease of soft tissue contusion, articular sprain, rheumatic arthritis, rheumatic arthritis, treating swelling and pain by traumatic injury; Be a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compares a kind of Herba Schnabeliae Oligophyllae medicine for external use of better efficacy with existing similar medicine for external use curative effect.Herba Schnabeliae Oligophyllae medicine for external use of the present invention was once done a large amount of clinical trials in early stage, inferior between the 1998-2005 to over one hundred example on the patient treatment case, comprise be used for the treatment of traumatic injury, rheumatic bones and muscles pain, fall decrease that joint swells and ache, rheumatic arthritis, traumatic injury muscles and bones are hindered, blood stasis swells and ache, the disease of soft tissue contusion, articular sprain, rheumatic arthritis, rheumatic arthritis, treating swelling and pain by traumatic injury, do not see untoward reaction during the treatment.Total effective rate is more than 82%, and the treatment works well.
Using method:
This medicine is a medicine for external use, and oral administration is cleaned the affected part with hot water, dabs in the affected part with the drenched medicinal liquid of absorbent cotton, rubs with the hands with the palm of the hand and beats affected part, makes affected part rub extremely heating with the hands for good, every day 3-6 time.
The specific embodiment:
Describe embodiments of the invention below in detail:
Embodiment 1:
A kind of Herba Schnabeliae Oligophyllae medicine for external use provided by the present invention is made up of the component of following parts by weight; Herba Schnabeliae Oligophyllae 1-16 part, Radix Berchemiae Giraldianae 1-14 part, Herba Euonymi Bungeani 1-8 part, Rhizoma Anemones flaccidae 1-10 part, Radix seu Caulis Kadsurae Heteroclitae 1-10 part, Herba Psiloti Nudi 1-10 part, Radix Doellingeriae 1-10 part, ethanol (concentration is 75%) 30-255 part.
Embodiment 2:
Optimization formula of the present invention is:
14 parts of Herba Schnabeliae Oligophyllaes, 12 parts of Radix Berchemiae Giraldianae, 6 parts of Herba Euonymi Bungeani, 8 parts of Rhizoma Anemones flaccidae, Radix seu Caulis Kadsurae Heteroclitae 8,8 parts of Herba Psiloti Nudis, 8 parts of Radix Doellingeriaes, 215 parts of ethanol (concentration is 75%).
Preparation method of the present invention is: at first with above-mentioned Herba Schnabeliae Oligophyllae, Radix Berchemiae Giraldianae, Herba Euonymi Bungeani, Rhizoma Anemones flaccidae, Radix seu Caulis Kadsurae Heteroclitae, Herba Psiloti Nudi, Radix Doellingeriae, the single granularity control of grinding into is as the grain of rice between the size respectively, granule after each single pulverizing is mixed in proportion mixes together evenly, be placed in the container then, and allocate ethanol (concentration is 75%) into, stir in the sealed container of back, according to the modern Chinese medicine processing technology or after soaking 15 days, the mixture solution after handling packed into by the required metering of client to get product in the bottle.

Claims (3)

1, a kind of Herba Schnabeliae Oligophyllae medicine for external use is characterized in that: Herba Schnabeliae Oligophyllae, Radix Berchemiae Giraldianae, Herba Euonymi Bungeani, Rhizoma Anemones flaccidae, Radix seu Caulis Kadsurae Heteroclitae, Herba Psiloti Nudi, Radix Doellingeriae, ethanol (concentration is 75%) are formed.
2, a kind of Herba Schnabeliae Oligophyllae medicine for external use according to claim 1, it is characterized in that: the component by following parts by weight is formed; Herba Schnabeliae Oligophyllae 1-16 part, Radix Berchemiae Giraldianae 1-14 part, Herba Euonymi Bungeani 1-8 part, Rhizoma Anemones flaccidae 1-10 part, Radix seu Caulis Kadsurae Heteroclitae 1-10 part, Herba Psiloti Nudi 1-10 part, Radix Doellingeriae 1-10 part, ethanol 30-255 part.
3, a kind of Herba Schnabeliae Oligophyllae medicine for external use according to claim 1, it is characterized in that: the component by following parts by weight is formed; 14 parts of Herba Schnabeliae Oligophyllaes, 12 parts of Radix Berchemiae Giraldianae, 6 parts of Herba Euonymi Bungeani, 8 parts of Rhizoma Anemones flaccidae, Radix seu Caulis Kadsurae Heteroclitae 8,8 parts of Herba Psiloti Nudis, 8 parts of Radix Doellingeriaes, 215 parts of ethanol.
CNB2005100989293A 2005-09-11 2005-09-11 A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis Expired - Fee Related CN100551418C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100989293A CN100551418C (en) 2005-09-11 2005-09-11 A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100989293A CN100551418C (en) 2005-09-11 2005-09-11 A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis

Publications (2)

Publication Number Publication Date
CN1739740A true CN1739740A (en) 2006-03-01
CN100551418C CN100551418C (en) 2009-10-21

Family

ID=36092365

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100989293A Expired - Fee Related CN100551418C (en) 2005-09-11 2005-09-11 A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis

Country Status (1)

Country Link
CN (1) CN100551418C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110286953A1 (en) * 2009-02-09 2011-11-24 Shiseido Company, Ltd. Whitening agent, anti-aging agent, and anti-oxidant agent
CN105663392A (en) * 2016-02-15 2016-06-15 庄海涛 Traditional Chinese medicine preparation for treating gouty arthritis

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110286953A1 (en) * 2009-02-09 2011-11-24 Shiseido Company, Ltd. Whitening agent, anti-aging agent, and anti-oxidant agent
US9364423B2 (en) 2009-02-09 2016-06-14 Shiseido Company, Ltd. Whitening agent, anti-aging agent, and antioxidant agent
CN105663392A (en) * 2016-02-15 2016-06-15 庄海涛 Traditional Chinese medicine preparation for treating gouty arthritis

Also Published As

Publication number Publication date
CN100551418C (en) 2009-10-21

Similar Documents

Publication Publication Date Title
CN1739620A (en) Externally applied for dispelling wind and dredging meridian passage
CN1742895A (en) External-use medicine of Herba sarcandrae
CN100551418C (en) A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis
CN1813944A (en) External-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals
CN1739693A (en) Externally applied medicine of dunn tongoloa root
CN100551415C (en) A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis
CN1739624A (en) Externally applied medicine of aizoon stonecrop root
CN100518784C (en) Externally applied medicine of traumatic injury, rheumatic arthralgia
CN1739711A (en) Externally applied medicine of rhodiola root
CN1739644A (en) Externally applied medicine of fortune silene herb
CN1739636A (en) Externally applied medicine of Chinese tinospora stem
CN100534512C (en) Externally applied medicine of Yunan camptandra root
CN1739690A (en) Externally applied medicine of Himalayan blueberry herb
CN100518791C (en) Externally applied medicine of traumatic injury, rheumatic arthralgiaf
CN100534475C (en) Externally applied medicine of sequin lobelia
CN1739646A (en) Externally applied medicine of thickleaf croton root
CN1739649A (en) Externally applied wound treating medicine of miquel brookweed
CN1739634A (en) Externally applied medicine of safflower
CN100518778C (en) Externally applied medicine of traumatic injury, rheumatic arthralgia
CN100542549C (en) A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis
CN1742856A (en) Radix aconitic kusnezoffii external-use medicine
CN1751709A (en) External use medicine for treating traumatic injury
CN1813974A (en) Wind-repellent collateral-flow-activating pain-relieving medicine of Radix Acanthopanacis Trifoliati
CN1742815A (en) External-use medicine of lysimachia root
CN1739692A (en) Externally applied medicine of Chinese starjasmine stem

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20091021

Termination date: 20100911